Search results for: Health Policy and Regulation
Filter search results
Vaccines, Antivirals, Lockdowns and COVID: Lessons from the Pandemic
20 October 2022, 3:00pm
…threats. The panel Chair: Professor Graham Cookson | Chief Executive of the Office of Health Economics Stuart Carroll | Director Market Access and Policy Affairs for the UK and Ireland,…
NICE and EuroQol Research Foundation to Support New EQ-5D-5L Valuation Study
24 October 2019
…and was part of the first wave of studies including China, Canada, Spain, and the Netherlands. The study was funded by the National Institute for Health Research (NIHR) and was…
OHE Seminar Launches ‘An EQ-5D-5L Value Set for England’
13 November 2014
…for England’. The seminar was well attended, with participants from the Department of Health, NICE, NHS England, the EuroQol Group, academia and pharmaceutical industry. The EQ-5D is widely used to…
Two New Papers on EQ-5D-5L Valuation in Ireland
21 August 2018
…and O’Neill, C., 2018. Euthanasia, religiosity and the valuation of health states: results from an Irish EQ5D5L valuation study and their implications for anchor values. Health and Quality of Life…
Contract Theory: Nobel Offerings to Health Economics
11 October 2016
…care providers, pricing agreements between health care systems and pharmaceutical firms, and the public-private health care provision debate. Bengt Holmström in Moral Hazard and Observability demonstrated that rewards and punishments…
In Memoriam Adam Wagstaff 1959-2020
15 May 2020
…care, incentives and the behaviour of agents in health care provision and health care policy, the measurement of health and associated inequalities of course, the pharmaceutical industry, bibliometry, health econometrics….
Universal Health Coverage: The Holy Grail? 21st Annual Lecture Publication.
31 January 2015
…It is now available as a publication and can be downloaded here. Health services available to the entire population free of charge, and providing the best health advice and…
Assessment of the Impact of Orphan Medicinal Products on the European Economy and Society
1 November 2010
…Europe. Societal effects of the OMP Regulation have been important — including, for example, improvements in treatment that positively affect the lives of both patient and caregiver and the development…
An Issues Panel: Developing Cost Effectiveness for Decision Making: What can be Learnt from “Value Based Pricing”?
29 July 2015
…Based Pricing”?” which included a contribution from Adrian Towse, Director of the OHE. The panel was organised and chaired by Allan Wailoo, Professor of Health Economics and Director of the…